https://dukespace.lib.duke.edu/items/e58e6a3f-4996-4db1-88b9-9896ea9f4f50
Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens.
Sipuleucel-T, an autologous cellular immunotherapy, was approved to treat metastatic castration-resistant prostate cancer in 2010 in the United States....
https://pubmed.ncbi.nlm.nih.gov/26000580/
Optimizing the efficiency and quality of sipuleucel-T delivery in an academic institution
Early patient identification and education on treatment rationale, delivery, and expectations help ensure a successful sipuleucel-T treatment experience. A...
https://www.cancer.gov/research/participate/clinical-trials/intervention/sipuleucel-t
Clinical Trials Using Sipuleucel-T - NCI
NCI supports clinical trials that test new and more effective ways to treat cancer. Find clinical trials studying sipuleucel-t.
clinical trialsusingnci